John Renger, Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 26,105 shares at $30.00 ($786K) on 2022-07-05, disclosed to the SEC on 2022-07-07.
Open-market sale of $786k CERE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 25,000 | $750K | 95.4% |
| 2 | $32.50 | 1,105 | $36K | 4.6% |
| Total | $30.11 avg | 26,105 | $786K | 100% |
| Filing → |
| CERE | SELL | 2022-10-06 | $750K | — | Filing → |
| CERE | SELL | 2022-08-12 | $4.5M | — | Filing → |
| CERE | SELL | 2022-08-09 | $1.0M | — | Filing → |